FdaApplication
ANDA 213362
Identifiers
- fda_app_no: ANDA213362
Properties
| Property | Value |
|---|---|
| applicant_name | DAITO PHARMACEUTICAL CO LTD |
| application_type | ANDA |
| approval_date | 2023-08-07 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| METHOTREXATE SODIUM | METHOTREXATE SODIUM | EQ 2.5MG BASE | TABLET;ORAL |
1 product